Sr. Manager, Ethics and Compliance

Overview

The Senior Manager, Global Compliance Operations, will report to the Director of Global Compliance Monitoring and Anti-Bribery/Anti-Corruption (ABAC) Programs, and is responsible for the oversight, implementation and continuous improvement of compliance systems, tools, processes, and programs designed to identify and mitigate healthcare compliance risk, drive operational efficiency, and enhance the effectiveness of the Global Compliance program and the broader enterprise. 

The Senior Manager will be responsible for helping advance Alnylam’s Global Compliance Program and enterprise efficiencies by partnering cross-functionally with stakeholders in Internal Audit, Finance, IT, and Legal to enhance compliance tools, controls and systems within an end-to-end procure-to-pay process, to optimize end-user experience.  The Senior Manager will coordinate across the Ethics & Compliance organization, collaborating with key business stakeholders across the Company, and present to country-level, franchise and functional leadership.  The Senior Manager must possess an innovative mindset and take a practical, solutions-oriented approach to: (1) leveraging technology to evolve, harmonize, streamline, and strengthen the Global Compliance program and the broader enterprise procure-to-pay process; (2) supporting Compliance business partners in carrying out their advisory responsibilities; and (3) enabling end-users in the broader business to conduct their daily work in a compliant, but efficient manner.

Key Responsibilities

The Senior Manager serves as a healthcare compliance risk SME in the management of tools with embedded compliance controls, specifically:

• Designing and supporting continuous improvements to the compliance review and approval systems in such areas as external funding, healthcare professional and patient engagements and interactions, and conflicts of interest, while strengthening the ABAC risk mitigation and user experience;
• Responding timely to inquiries from business stakeholders on questions regarding compliance review and approval systems;
• Partnering with Finance to develop, implement and continuously improve a Third-Party Risk Management System using a risk-based approach;
• Serving as the Subject Matter Expert in the Third-Party Risk Management Process for ABAC, Modern Slavery, Conflicts of Interest and Sanctions;
• Partnering with Finance to support and maintain accurate books and records and the overall company-wide control structure;
• Developing and executing trainings on the Compliance review and approval system, Third-Party Risk Management and other healthcare compliance related trainings;
• Supporting and executing on a global monitoring and data analytics program that leverages technology to collect robust and standardized data from multiple sources to produce meaningful, dynamic, and actionable reports and dashboards with insights for both Compliance professionals and business leaders on potential outliers and trends;
• Reviewing transactions from Global Monitoring tool to address any risks identified; and
• Drafting concise and accurate summaries of output from the monitoring and data analytics programs, and creating presentations of key issues, findings, trends, outcomes, and necessary remediation.

Qualifications

• 5+ years’ experience with increasing responsibility in compliance, audit, controllership, consulting or legal roles; focus on operations in the pharmaceutical or life science industry, is strongly preferred;
• Bachelor’s Degree required
• Direct experience in designing, implementing, overseeing, and improving compliance systems and tools; data analytics and monitoring; and third party risk management processes;
• Demonstrated ability to collaborate and influence cross-functionally with US and ex-US personnel;
• Knowledge of laws and regulations applicable to global pharmaceutical companies, including, the U.S. Foreign Corrupt Practices Act, US fraud and abuse and false claims laws, and industry codes on interactions with healthcare professionals;
• Possess an innovative mindset and must take a practical, solutions-oriented approach;
• Strong commitment to ethics and integrity in all aspects of their work;
• Must be able to work and lead collaboratively in a team environment with a wide variety of company personnel on a broad range of matters, including Compliance, Legal, Finance, and business colleagues;  
• Ability to manage multiple tasks simultaneously, to work independently and manage discrete areas of responsibility with limited supervision, and to flourish in a fast-paced environment;
• Ability to thrive in a proactive ethical culture in which compliance and business objectives are mutually reinforcing; strong motivation and ability to champion a comprehensive compliance program and compliance culture that are integrated with and embedded in Alnylam’s business;
• Excellent organizational and time management skills, refined communication skills (verbal and written) with fluency in written and spoken English required;
• Travel will be required on occasion to Alnylam offices in the U.S. and overseas

#LI-Hybrid

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.